Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 116.6
2 %
$ 145 B
Market Cap
25.29
P/E
GILD - LONG-TERM DEBT
Long-term Debt GILD - Gilead Sciences, Inc.
23.2 B
LAST VALUE
-4.95%
2 YEAR CAGR
-1.15%
5 YEAR CAGR
19.40%
10 YEAR CAGR